160 related articles for article (PubMed ID: 3929829)
21. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
22. Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease.
Cumming AM; Fildes S; Cumming IR; Wensley RT; Redding OM; Burn AM
Br J Haematol; 1990 Jun; 75(2):234-9. PubMed ID: 2115374
[TBL] [Abstract][Full Text] [Related]
23. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
Johnstone IB; Crane S
Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
[TBL] [Abstract][Full Text] [Related]
24. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
Joist JH; Cowan JF; Zimmerman TS
N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
[TBL] [Abstract][Full Text] [Related]
25. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
[TBL] [Abstract][Full Text] [Related]
26. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
27. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
[TBL] [Abstract][Full Text] [Related]
28. Acquired von Willebrand's syndrome with lupus-like serology.
Igarashi N; Miura M; Kato E; Matsuda T; Itoh K; Abildgaard CF; Shimizu M; Koizumi S; Sato T; Taniguchi N
Am J Pediatr Hematol Oncol; 1989; 11(1):32-5. PubMed ID: 2496614
[TBL] [Abstract][Full Text] [Related]
29. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
30. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
31. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
Stokol T; Parry B
J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
[TBL] [Abstract][Full Text] [Related]
33. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
34. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
[TBL] [Abstract][Full Text] [Related]
35. A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structure.
Gralnick HR; Williams SB; McKeown LP; Maisonneuve P; Jenneau C; Sultan Y
Am J Hematol; 1987 Mar; 24(3):259-66. PubMed ID: 3493688
[TBL] [Abstract][Full Text] [Related]
36. In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease.
Gralnick HR; Williams SB; McKeown LP; Maisonneuve P; Jenneau C; Sultan Y; Rick ME
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5968-72. PubMed ID: 2994057
[TBL] [Abstract][Full Text] [Related]
37. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.
Aihara M; Sawada Y; Ueno K; Morimoto S; Yoshida Y; de Serres M; Cooper HA; Wagner RH
Thromb Haemost; 1986 Apr; 55(2):263-7. PubMed ID: 3087003
[TBL] [Abstract][Full Text] [Related]
38. An electroblotting technique for the detection of factor VIII/von Willebrand factor multimers in plasma.
Furlong BL; Peake IR
Br J Haematol; 1983 Apr; 53(4):641-53. PubMed ID: 6403025
[TBL] [Abstract][Full Text] [Related]
39. On laboratory problems in diagnosing mild von Willebrand's disease.
Blombäck M; Eneroth P; Andersson O; Anvret M
Am J Hematol; 1992 Jun; 40(2):117-20. PubMed ID: 1585909
[TBL] [Abstract][Full Text] [Related]
40. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
